Jungwoo Eperisone Hydrochloride Tablets

Adult dose

Adults: Eperisone Hydrochloride at 50 mg per dose, administered orally three times a day after meals. Adjust dosage as appropriate based on age and symptoms.

This medication should not be used in certain patients. First, it should not be administered to patients with an allergic reaction to this medication. Additionally, it should not be used in patients with myasthenia gravis. This medication contains lactose, so it should not be given to patients with genetic issues such as lactose intolerance, lactose enzyme deficiency, or glucose-galactose absorption disorders. When using this drug, careful administration is required in patients with a history of drug hypersensitivity or impaired liver function. Due to the potential for liver function to worsen, patients with liver impairment need to be especially cautious. Various side effects may appear during administration, so close observation is required. Rarely, shock may occur, so if symptoms present, the administration should be stopped immediately and appropriate treatment pursued. As liver levels may increase, if liver dysfunction is suspected, administration should cease. It may also affect kidney function, so caution is needed if proteinuria or elevated BUN levels are observed. Blood abnormalities such as anemia may also rarely occur, so symptoms should be closely monitored. Skin rash or itching may occur, and neurological symptoms such as insomnia, drowsiness, headache, and limb paralysis may also manifest. Gastrointestinal issues such as nausea, vomiting, anorexia, and abdominal pain may arise. Urological problems may include urinary retention or incontinence. Systemically, weakness, dizziness, and decreased muscle tone may occur, so caution is important. Additionally, serious skin adverse reactions, such as Stevens-Johnson syndrome, may rarely occur; thus, if symptoms such as fever, rash, blisters, itching, conjunctival injection, or stomatitis are present, use should be discontinued immediately. While taking this medication, symptoms such as weakness, unsteadiness, or drowsiness may occur; therefore, if these symptoms are present, the dose should be reduced or administration should be stopped. Furthermore, drowsiness or decreased attention may occur, so it is advisable to avoid driving or operating hazardous machinery. This medication may cause circadian rhythm disturbances when used with similar drugs, so caution is advised during co-administration. During pregnancy, safety is not established; thus, in women who could become pregnant, it should be administered only when the benefits of treatment outweigh the risks. If breastfeeding, it is preferable to avoid administration, and if unavoidable, it is advised to discontinue breastfeeding. In children, safety has not been adequately confirmed, and there is limited experience in usage, so caution is necessary. In the elderly, considering the decline in physical functions, careful usage is required, such as reducing the dose of the medication.

Serious side effects

Shock (anaphylactic reaction), angioedema, liver dysfunction (elevated ALT, AST, ALP), kidney dysfunction (proteinuria, elevated BUN), anemia, toxic epidermal necrolysis and mucocutaneous-eye syndrome (Stevens-Johnson syndrome)

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• limb paralysis
• rigidity
• limb tremor
• nausea
• vomiting

This medication should be stored in a tightly sealed container to prevent air ingress, and it is recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the efficacy of the medication and prevents deterioration.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle